Johannes Brachmann

Tina Baykaner is an Assistant Professor in the Department of Internal Medicine, Division of Cardiovascular Medicine and Electrophysiology. Following internal medicine residency and cardiovascular medicine a at University of California, San Diego and electrophysiology fellowship at Stanford University, Dr. Baykaner joined Stanford University faculty in 2018. Dr. Baykaner’s current research interests include outcomes research, epidemiology and mechanisms of rhythm disorders. She is currently funded by the National Institutes of Health to study patient related outcomes regarding atrial fibrillation (AF) ablation. She received prior research funding from American Heart Association and Heart Rhythm Society.

Roderick Tung, MD, is a specialist in cardiac electrophysiology. He is an expert in the management of heart rhythm disorders (arrhythmias), with a particular focus on advanced therapies for atrial fibrillation and ventricular arrhythmias. He specializes in catheter ablation — a procedure that targets and cauterizes abnormal tissue to eliminate heart rhythm irregularities. Dr. Tung is also one of a few electrophysiologists in the world who routinely performs epicardial mapping and ablation.

In addition to Dr. Tung's clinical work, he is dedicated to researching and investigating new and innovative ways to treat and manage arrhythmias. He currently serves as the principal investigator for several prospective clinical trials focusing on the role of robotic navigation, high-density multi-electrode mapping and early intervention to improve patient survival. Dr. Tung's work has been published in numerous respected, peer-reviewed journals, including Circulation, Journal of the American College of Cardiology, Heart Rhythm, Circulation: Arrhythmia Electrophysiology and Journal of Cardiovascular Electrophysiology.

Dr. Kamel is the Helen and Albert Moon Professor, Chief of Neurocritical Care, and Vice Chair for Research in the Department of Neurology at Weill Cornell Medicine. He is the Director of the Clinical and Translational Neuroscience Unit in the Feil Family Brain and Mind Research Institute at Weill Cornell Medicine. His research focuses on the relationship between cardiac disease and stroke. He was a principal investigator and protocol lead for the NIH-funded ARCADIA trial, which tested antithrombotic strategies in patients with stroke and atrial cardiopathy. He is also a principal investigator of the NIH-funded ASPIRE trial, which is testing antithrombotic strategies in patients with atrial fibrillation and intracerebral hemorrhage. He serves on the NIH StrokeNet Executive Committee and chairs its Prevention Working Group. He has published over 400 scientific publications, including in leading journals such as NEJM and JAMA.

Adrian F. Hernandez, MD is a cardiologist, clinical trialist, and academic leader at Duke University. He serves as Vice Dean of the Duke University School of Medicine and is Executive Director of the Duke Clinical Research Institute (DCRI), one of the world’s leading academic clinical research organizations, where he oversees a broad portfolio of clinical trials and evidence-generation initiatives spanning cardiovascular disease, metabolic disorders, infectious diseases, and other major public health challenges.

Dr. Hernandez is internationally recognized for his contributions to clinical research, pragmatic trial design, implementation science, and the development of innovative approaches to generating real-world evidence. Throughout his career, he has led and collaborated on numerous large-scale national and global studies that have informed clinical practice guidelines, regulatory decision-making, and health policy. His work focuses on improving the quality, efficiency, and applicability of clinical research through novel trial designs, digital health technologies, artificial intelligence, and learning health systems. He has published over 800 publications and is an elected member of the American Society for Clinical Investigation, the Association of American Physicians and chairs the board of directors of the Reagan-Udall Foundation.

Jason Andrade is the Director of Electrophysiology at Vancouver General Hospital in Canada. He is a Professor of Medicine at the University of British Columbia (UBC). He is the current co-chair of the Canadian Cardiovascular Society (CCS) Device Therapy Guidelines, former co-chair of the CCS Atrial Fibrillation Guidelines, past chair of the Canadian Heart Rhythm Society Device Committee, and inaugural medical chair for Heart Rhythm Disease for the province of British Columbia. He has authored over 370 publications and was the PI for the CIRCA-DOSE, EARLY-AF/PROGRESIVE-AF, CRYO-LATS and OPTIMAL AF-HF randomized trials.